Trachette L. Jackson
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Mathematics, General Biophysics, Cell BiologyGoogle:
"Trachette Jackson"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Jain HV, Norton KA, Prado BB, et al. (2022) SMoRe ParS: A novel methodology for bridging modeling modalities and experimental data applied to 3D vascular tumor growth. Frontiers in Molecular Biosciences. 9: 1056461 |
Nazari F, Oklejas AE, Nör JE, et al. (2020) In silico models accurately predict in vivo response for IL-6 blockade in head and neck cancer. Cancer Research |
Yu A, Koenigsknecht MJ, Hens B, et al. (2019) Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug Dissolution. The Aaps Journal. 22: 3 |
Nazari F, Pearson AT, Nör JE, et al. (2018) A mathematical model for IL-6-mediated, stem cell driven tumor growth and targeted treatment. Plos Computational Biology. 14: e1005920 |
Nazari F, Oklejas AE, Nör JE, et al. (2018) Abstract 925: In silico models accurately predict in vivo response for IL-6 blockade in head and neck cancer Cancer Research. 78: 925-925 |
Pearson AT, Ingram P, Bai S, et al. (2017) Sampling from single-cell observations to predict tumor cell growth in-vitro and in-vivo. Oncotarget. 8: 111176-111189 |
Farhat A, Jiang D, Cui D, et al. (2017) An Integrative Model of Prostate Cancer Interaction with the Bone Microenvironment. Mathematical Biosciences |
Jain H, Jackson T. (2017) Mathematical Modeling of Cellular Cross-Talk Between Endothelial and Tumor Cells Highlights Counterintuitive Effects of VEGF-Targeted Therapies. Bulletin of Mathematical Biology |
Pearson AT, Jackson TL, Nör JE. (2016) Modeling head and neck cancer stem cell-mediated tumorigenesis. Cellular and Molecular Life Sciences : Cmls |
Pearson AT, Finkel KA, Warner KA, et al. (2016) Patient-derived xenograft (PDX) tumors increase growth rate with time. Oncotarget |